5-carboxamidotryptamine has been researched along with Arteriosclerosis in 2 studies
5-carboxamidotryptamine: agonist of 5-HT receptor; structure given in first source
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujiwara, T | 1 |
Chiba, S | 1 |
Ishida, T | 1 |
Kawashima, S | 1 |
Sakoda, T | 1 |
Shimokawa, Y | 1 |
Miwa, Y | 1 |
Inoue, N | 1 |
Ueyama, T | 1 |
Shiomi, M | 1 |
Akita, H | 1 |
Yokoyama, M | 1 |
2 other studies available for 5-carboxamidotryptamine and Arteriosclerosis
Article | Year |
---|---|
Augmented responses to 5-HT2-receptor-mediated vasoconstrictions in atherosclerotic rabbit common carotid arteries.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Arteriosclerosis; Carotid Arteries; Disease Models, | 1995 |
Serotonin-induced hypercontraction through 5-hydroxytryptamine 1B receptors in atherosclerotic rabbit coronary arteries.
Topics: Animals; Arteriosclerosis; Calcium; Coronary Vessels; Dose-Response Relationship, Drug; Female; In V | 2001 |